Cannabigerol, a small non-psychoactive component of cannabis, shows significant promise as a treatment for glaucoma, multiple sclerosis and skin diseases, but its mostly unavailable in the...
Cannabigerol: What Exactly is it? Here’s a bite-sized primer on cannabigerol, commonly known as CBG, and its place on the forefront of cannabinoid research. What is CBG?...
Although colon cancer is the second leading cause of cancer-related deaths in the United States, there is new data that suggests that a large majority of...